Back to BAX Stock Lookup

Baxter Int'l (BAX) – Press Releases

Oct 24, 2014 09:00 AM FDA Approves Baxter’s OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence], for Acquired Hemophilia A
Oct 22, 2014 04:15 PM Baxter to Present at the 2014 Credit Suisse Healthcare Conference
Oct 20, 2014 09:00 AM Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency
Oct 16, 2014 07:00 AM Baxter’s Third Quarter Financial Results Exceed Guidance
Oct 9, 2014 04:35 PM Baxter International Third Quarter 2014 Financial Results Conference Call
Oct 8, 2014 09:15 AM Baxter Recognized for Commitment to Women's Healthcare Careers
Oct 3, 2014 07:00 AM Rockwell Medical Enters Into Exclusive Long-Term Agreement With Baxter Healthcare to Commercialize Rockwell's Hemodialysis Concentrates
Oct 1, 2014 09:15 AM Baxter International Inc. Recognized by Healthcare Businesswomen’s Association with ACE Award for Its Baxter Women Leaders Business Resource Group
Sep 29, 2014 04:15 PM Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business
Sep 26, 2014 04:56 AM PharmaEngine and Merrimack Amend MM-398 License Agreement
Sep 25, 2014 04:15 PM Baxter International Third Quarter 2014 Financial Results Conference Call
Sep 24, 2014 07:00 AM Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398
Sep 15, 2014 09:00 AM FDA Approves Baxter’s RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B
Sep 12, 2014 07:02 PM FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency
Sep 10, 2014 04:30 PM Baxter Announces Baxalta as the Name of New Global Biopharmaceutical Company
Aug 21, 2014 09:00 AM Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients
Aug 19, 2014 04:30 PM Baxter Announces Hemodialysis Dialyzer Expansion in Opelika, Alabama
Aug 18, 2014 04:15 PM Baxter to Present at Morgan Stanley Global Healthcare Conference
Aug 7, 2014 09:00 AM Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite
Aug 4, 2014 09:00 AM FDA Approves Baxter’s FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container
Jul 31, 2014 01:55 PM FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency
Jul 30, 2014 08:02 AM Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

Back to BAX Stock Lookup